Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Pieters

Showing results (311-320 of 336) with videos related to

Pageof 34
Sort By:
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Blood|August 27, 2013
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALLArian van der Veer, Esmé Waanders, Rob Pieters, et al.
The Lancet. Haematology|June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemiaLiv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Haematologica|July 28, 2011
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemiaBrian V Balgobind, Iris H I M Hollink, Susan T C J M Arentsen-Peters, et al.
Blood Cancer Journal|August 28, 2024
Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemiaAimée S R Westerveld, Pien Roesthuis, Helena J H van der Pal, et al.
Blood|January 3, 2012
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group studyHuining Kang, Carla S Wilson, Richard C Harvey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Nature Medicine|June 15, 2023
A joint international consensus statement for measuring quality of survival for patients with childhood cancerRebecca J van Kalsbeek, Melissa M Hudson, Renée L Mulder, et al.
Cancer Cell|April 13, 2011
Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemiaIrene Homminga, Rob Pieters, Anton W Langerak, et al.
Haematologica|October 26, 2010
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaBrian V Balgobind, Marry M Van den Heuvel-Eibrink, Renee X De Menezes, et al.
Pageof 34

Showing results (311-320 of 336) with videos related to

Sort By:
Pageof 34
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Blood|August 27, 2013
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALLArian van der Veer, Esmé Waanders, Rob Pieters, et al.
The Lancet. Haematology|June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemiaLiv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Haematologica|July 28, 2011
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemiaBrian V Balgobind, Iris H I M Hollink, Susan T C J M Arentsen-Peters, et al.
Blood Cancer Journal|August 28, 2024
Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemiaAimée S R Westerveld, Pien Roesthuis, Helena J H van der Pal, et al.
Blood|January 3, 2012
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group studyHuining Kang, Carla S Wilson, Richard C Harvey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Nature Medicine|June 15, 2023
A joint international consensus statement for measuring quality of survival for patients with childhood cancerRebecca J van Kalsbeek, Melissa M Hudson, Renée L Mulder, et al.
Cancer Cell|April 13, 2011
Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemiaIrene Homminga, Rob Pieters, Anton W Langerak, et al.
Haematologica|October 26, 2010
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaBrian V Balgobind, Marry M Van den Heuvel-Eibrink, Renee X De Menezes, et al.
Pageof 34